Successful ibrutinib treatment for pulmonary involvement in a post‐transplant patient with inherited bone marrow failure syndrome and very short telomeres
- 9 September 2024
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (12) , e31314
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantationInternational Journal of Hematology, 2023
- Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?Bone Marrow Transplantation, 2022
- Ibrutinib for Chronic Pulmonary Graft-Versus-Host-Disease after Progression on Prior TherapyBlood, 2019
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Ibrutinib for chronic graft-versus-host disease after failure of prior therapyBlood, 2017
- Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantationRespiratory Medicine, 2014
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis CongenitaTransplantation and Cellular Therapy, 2013